WO2023042107 - A STABLE READY TO DILUTE INJECTABLE PHARMACEUTICAL FORMULATION OF MITOMYCIN
National phase entry:
Publication Number
WO/2023/042107
Publication Date
23.03.2023
International Application No.
PCT/IB2022/058697
International Filing Date
15.09.2022
Title **
[English]
A STABLE READY TO DILUTE INJECTABLE PHARMACEUTICAL FORMULATION OF MITOMYCIN
[French]
FORMULATION PHARMACEUTIQUE INJECTABLE, STABLE ET PRÊTE À DILUER DE MITOMYCINE
Applicants **
INTAS PHARMACEUTICALS LTD.
Corporate House, Near Sola Bridge
S. G. Highway, Thaltej
Gujarat, Ahmedabad 380054, IN
Inventors
SHAH, Nisarg Pravinkumar
Intas Pharmaceuticals Ltd. – Astron Division
Plot 457/458, Sarkhej-Bavla Highway
Matoda, Tal.: Sanand
Gujarat, Ahmedabad 382210, IN
SONI, Maheshkumar Parasmalji
Intas Pharmaceuticals Ltd. – Astron Division
Plot 457/458, Sarkhej-Bavla Highway
Matoda, Tal.: Sanand
Gujarat, Ahmedabad 382210, IN
DADHANIYA, Dhavalkumar Vallabhadas
Intas Pharmaceuticals Ltd. – Astron Division
Plot 457/458, Sarkhej-Bavla Highway
Matoda, Tal.: Sanand
Gujarat, Ahmedabad 382210, IN
SINGH, Ajeet Kumar
Intas Pharmaceuticals Ltd. – Astron Division
Plot 457/458, Sarkhej-Bavla Highway
Matoda, Tal.: Sanand
Gujarat, Ahmedabad 382210, IN
SEHGAL, Ashish
Intas Pharmaceuticals Ltd. – Astron Division
Plot 457/458, Sarkhej-Bavla Highway
Matoda, Tal.: Sanand
Gujarat, Ahmedabad 382210, IN
Priority Data
202121042020
17.09.2021
IN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
IP India
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 972 | |
| EPO | Filing, Examination | 7067 | |
| Japan | Filing | 591 | |
| South Korea | Filing | 575 | |
| USA | Filing, Examination | 2710 |
Total: 11915 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The present invention relates to a stable ready to dilute (RTD) injectable pharmaceutical formulation of Mitomycin or a pharmaceutically acceptable salt thereof. The said formulation further comprises N, N - Dimethylacetamide (DMAC), Polyethylene glycol (PEG) and optionally other pharmaceutically acceptable excipients. Further, the present invention discloses process for the preparation of the said formulation.[French]
La présente invention concerne une formulation pharmaceutique injectable, stable et prête à diluer (RTD) de mitomycine ou d'un sel pharmaceutiquement acceptable de celle-ci. Ladite formulation comprend en outre du N, N-diméthylacétamide (DMAC), du polyéthylène glycol (PEG) et éventuellement d'autres excipients pharmaceutiquement acceptables. En outre, la présente invention concerne un procédé de préparation de ladite formulation.